Effects of Glutamine on Gastric Emptying of Low- and High-Nutrient Drinks in Healthy Young Subjects—Impact on Glycaemia
暂无分享,去创建一个
M. Horowitz | C. Rayner | J. Greenfield | D. Samocha-Bonet | Karen L. Jones | L. Trahair | D. Piscitelli | Yang T Du | Saima Ahmad | K. Jones | K. Jones
[1] J. Wishart,et al. Relationships of the early insulin secretory response and oral disposition index with gastric emptying in subjects with normal glucose tolerance , 2017, Physiological reports.
[2] J. Holst,et al. Glycemic Effects and Safety of L-Glutamine Supplementation with or without Sitagliptin in Type 2 Diabetes Patients—A Randomized Study , 2014, PloS one.
[3] M. Horowitz,et al. Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones , 2013, Diabetes Care.
[4] M. Horowitz,et al. Effects of Intraduodenal Glutamine on Incretin Hormone and Insulin Release, the Glycemic Response to an Intraduodenal Glucose Infusion, and Antropyloroduodenal Motility in Health and Type 2 Diabetes , 2013, Diabetes Care.
[5] J. Holst,et al. Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. , 2011, The Journal of nutrition.
[6] Á. Robles,et al. The effect of l-alanyl-l-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients* , 2011, Critical care medicine.
[7] D. Lobo,et al. A randomized crossover study of the effects of glutamine and lipid on the gastric emptying time of a preoperative carbohydrate drink. , 2011, Clinical nutrition.
[8] M. Teixeira,et al. The safety of oral use of L-glutamine in middle-aged and elderly individuals. , 2010, Nutrition.
[9] W. Uhl,et al. Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes , 2010, Regulatory Peptides.
[10] L. Marciani,et al. Gastric emptying of three liquid oral preoperative metabolic preconditioning regimens measured by magnetic resonance imaging in healthy adult volunteers: a randomised double-blind, crossover study. , 2009, Clinical nutrition.
[11] V. Vuksan,et al. Fiber facts: Benefits and recommendations for individuals with type 2 diabetes , 2009, Current diabetes reports.
[12] R. Campbell,et al. Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. , 2009, Journal of the American Pharmacists Association : JAPhA.
[13] B. Ginsberg. Factors Affecting Blood Glucose Monitoring: Sources of Errors in Measurement , 2009, Journal of diabetes science and technology.
[14] J. Holst. The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.
[15] A. Forbes,et al. Review article: glucagon‐like peptide 2 – current applications and future directions , 2007, Alimentary pharmacology & therapeutics.
[16] T. Hausken,et al. Measurements of gastric emptying of low‐ and high‐nutrient liquids using 3D ultrasonography and scintigraphy in healthy subjects , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[17] K. Wynne,et al. The role of oxyntomodulin and peptide tyrosine–tyrosine (PYY) in appetite control , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[18] T. Hausken,et al. Effects of Posture on Gastric Emptying, Transpyloric Flow, and Hunger After a Glucose Drink in Healthy Humans , 2006, Digestive Diseases and Sciences.
[19] Reawika Chaikomin,et al. Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes. , 2006, The Journal of clinical endocrinology and metabolism.
[20] P. Flakoll,et al. Glutamine supplementation increases postprandial energy expenditure and fat oxidation in humans. , 2006, JPEN. Journal of parenteral and enteral nutrition.
[21] D. Drucker. The biology of incretin hormones. , 2006, Cell metabolism.
[22] J. Holst,et al. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects. , 2005, Diabetes.
[23] G. Rutter,et al. Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells , 2004, Diabetologia.
[24] M. Camilleri,et al. Assessment of gastric accommodation: overview and evaluation of current methods , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[25] Dennis D. Kim,et al. Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. , 2003, The Journal of clinical endocrinology and metabolism.
[26] Claude Colette,et al. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). , 2003, Diabetes care.
[27] Rachel L. Batterham,et al. Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.
[28] A. Zinsmeister,et al. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus , 2002, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[29] M. Horowitz,et al. Gastric emptying in diabetes: clinical significance and treatment , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[30] R. Ratner. Controlling postprandial hyperglycemia. , 2001, The American journal of cardiology.
[31] M. Nauck. Is glucagon-like peptide 1 an incretin hormone? , 1999, Diabetologia.
[32] P. Flakoll,et al. Parenteral glutamine infusion alters insulin-mediated glucose metabolism. , 1998, JPEN. Journal of parenteral and enteral nutrition.
[33] J. Holst,et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. , 1997, American journal of physiology. Endocrinology and metabolism.
[34] J. Wishart,et al. Gastric emptying in early noninsulin-dependent diabetes mellitus. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] K. Hveem,et al. Scintigraphic measurement of gastric emptying and ultrasonographic assessment of antral area: relation to appetite. , 1996, Gut.
[36] J. Wishart,et al. The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjects , 1996, Diabetologia.
[37] J. Dent,et al. Role and integration of mechanisms controlling gastric emptying , 1994, Digestive Diseases and Sciences.
[38] J. Wishart,et al. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects , 1993, Diabetologia.
[39] H. Grill,et al. Dynamics of gastric emptying during and after stomach fill. , 1992, The American journal of physiology.
[40] J. Dent,et al. Disordered gastric emptying: mechanical basis, assessment and treatment. , 1991, Bailliere's clinical gastroenterology.
[41] J. Meyer,et al. Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient. , 1989, The American journal of physiology.
[42] P. McHugh,et al. Regulation of the gastric emptying of glucose. , 1983, Gastroenterology.
[43] Karen L Jones,et al. Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia. , 2010, The Journal of clinical endocrinology and metabolism.
[44] J. Holst,et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. , 2009, The American journal of clinical nutrition.
[45] M. Henderson,et al. Oral glutamine in paediatric oncology patients: a dose finding study , 2003, European Journal of Clinical Nutrition.
[46] E. Feskens,et al. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.